ADAR1 Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $294K | Hold |
17,000
| – | – | 0.05% | 132 |
|
|
2025
Q1 | $372K | Buy |
17,000
+2,000
| +13% | +$43.7K | 0.07% | 113 |
|
|
2024
Q4 | $479K | Sell |
15,000
-2,252
| -13% | -$71.9K | 0.1% | 106 |
|
|
2024
Q3 | $498K | Sell |
17,252
-3,398
| -16% | -$98K | 0.08% | 109 |
|
|
2024
Q2 | $792K | Sell |
20,650
-5,050
| -20% | -$194K | 0.15% | 72 |
|
|
2024
Q1 | $1.51M | Buy |
+25,700
| New | +$1.51M | 0.34% | 46 |
|